New scan could spot prostate cancer more accurately

NCT ID NCT05847166

Recruiting now Diagnosis Sponsor: NCBJ Polatom: Narodowe Centrum Badań Jądrowych Polatom Source: ClinicalTrials.gov ↗

First seen Apr 17, 2026 · Last updated May 11, 2026 · Updated 4 times

Summary

This study is testing a new imaging agent called PSMA-T4 to see if it can safely and accurately find prostate cancer lesions. About 80 adults with prostate cancer will receive an injection of this agent and then have a special scan. The goal is to improve how doctors diagnose and plan treatment for prostate cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

4. Wojskowy Szpital Kliniczny z Polikliniką SP ZOZ
COMPLETED

Wroclaw, Poland, 53-114, Poland
Centralny Szpital Kliniczny Uniwersytetu Medycznego
RECRUITING

Lodz, Poland, 92-216, Poland

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Centrum Onkologii im. prof. F. Łukaszczyka
RECRUITING

Bydgoszcz, Poland, 85-796, Poland

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
GAMMED Centrum Diagnostyczno-Lecznicze
RECRUITING

Warsaw, Poland, 02-351, Poland

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

PROSTATE CANCER